New COVID-19 guidelines for healthcare workers reveals giving patients the current gold standard care that’s grounded in science will help save thousands of lives.
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint venture of the University of Melbourne and Royal Melbourne Hospital, has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours.
Melbourne Health has extensive processes in place to safely assess and manage any patients with viral infections, including the novel coronavirus, COVID-19.
The Doherty Institute has welcomed a generous commitment of $1 million from Anthony Pratt and The Pratt Foundation, which will be directed towards the Australasian COVID-19 Trial (ASCOT).
In order to ensure we have appropriate staffing during the COVID-19 response, we are seeking expressions of interest for staff and volunteers in a number of areas.
Due to COVID-19, Peter MacCallum Cancer Centre, the Royal Women’s Hospital, the Royal Melbourne Hospital and The Royal Children’s Hospital are postponing the go-live of the Parkville Electronic Medical Record (EMR).
The Peter Doherty Institute for Infection and Immunity (Doherty Institute) – a joint venture between the University of Melbourne and The Royal Melbourne Hospital – has been awarded AU$3.2 million (US$2.15 million) by the Jack Ma Foundation through the Royal Melbourne Hospital Foundation to expedite the creation of a vaccine against COVID-19.
The Peter Doherty Institute for Infection and Immunity - a joint venture between the Royal Melbourne Hospital and The University of Melbourne - as well as The Burnet Institute have received $9.2 million dollars in funding from state and private donors in the past 24 hours to fight the spread of the novel coronavirus, COVID-19.
A Royal Melbourne Hospital researcher at the Walter and Eliza Hall Institute has helped reveal new details about how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack.
